admin February 1, 2019

Chimeric antigen receptor (CAR) T cells have been strikingly successful in the treatment of hematologic cancers but have not been effective against solid tumors thus far. A recent report by Samaha and colleagues presents a preclinical version of CAR T-cell therapy for a solid tumor, glioblastoma.…

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...